Us Physicalrapy Stock Performance
| USPH Stock | USD 82.36 1.88 2.23% |
The entity owns a Beta (Systematic Risk) of 1.64, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. At this point, US Physicalrapy has a negative expected return of -0.0728%. Please make sure to validate US Physicalrapy's coefficient of variation, semi variance, relative strength index, as well as the relationship between the treynor ratio and rate of daily change , to decide if US Physicalrapy performance from the past will be repeated at some future date.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days US Physicalrapy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, US Physicalrapy is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 6.8 | Five Day Return 7.77 | Year To Date Return 6.8 | Ten Year Return 59.21 | All Time Return 4.3 K |
Forward Dividend Yield 0.0228 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 1.8 | Dividend Date 2025-12-12 |
1 | U.S. Physical Therapy Assessing Valuation as Quarterly Earnings and Medicare Policy Shifts Draw Focus | 11/05/2025 |
2 | There May Be Underlying Issues With The Quality Of U.S. Physical Therapys Earnings | 11/14/2025 |
3 | US25 Million Share Buyback Authorization Might Change the Case for Investing in U.S. Physical Therapy | 11/21/2025 |
4 | COO Of US Physical Therapy Makes 52K Sale | 11/26/2025 |
5 | U.S. Physical Therapy, Inc. USPH Stock Holdings Boosted by Level Four Advisory Services LLC | 12/01/2025 |
6 | 4D Advisors Initiated a Big Position in USPH Worth Over 9 Million. Is the Stock a Buy | 12/09/2025 |
7 | How 4D Advisors US9 Million Stake and Top-Three Position Will Impact U.S. Physical Therapy Investors | 12/11/2025 |
| US Physicalrapy dividend paid on 12th of December 2025 | 12/12/2025 |
8 | U.S. Physical Therapy Stock Trades Up, Here Is Why | 12/22/2025 |
9 | The Bull Case For U.S. Physical Therapy Could Change Following 50 percent Stake In Eight-Clinic Platform | 01/05/2026 |
| Begin Period Cash Flow | 152.8 M | |
| Total Cashflows From Investing Activities | -149.4 M |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 8,981 in US Physicalrapy on October 8, 2025 and sell it today you would lose (557.00) from holding US Physicalrapy or give up 6.2% of portfolio value over 90 days. US Physicalrapy is currently does not generate positive expected returns and assumes 2.5238% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than USPH, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as US Physicalrapy, and traders can use it to determine the average amount a US Physicalrapy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0288
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | USPH |
Based on monthly moving average US Physicalrapy is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Physicalrapy by adding US Physicalrapy to a well-diversified portfolio.
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0844 | ||||
| Return On Asset | 0.0426 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 1.48 B | ||||
| Shares Outstanding | 15.2 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.38 X | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 671.35 M | ||||
| Gross Profit | 164.91 M | ||||
| EBITDA | 86.91 M | ||||
| Net Income | 45.6 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 295.23 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 33.12 X | ||||
| Cash Flow From Operations | 74.94 M | ||||
| Earnings Per Share | 2.53 X | ||||
| Market Capitalization | 1.28 B | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | 227.26 M | ||||
| Working Capital | 21.3 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.10 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| US Physicalrapy generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 12th of December 2025 US Physicalrapy paid $ 0.45 per share dividend to its current shareholders | |
| Latest headline from simplywall.st: The Bull Case For U.S. Physical Therapy Could Change Following 50 percent Stake In Eight-Clinic Platform |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |